Table 2.
MINORS quality assessment
| A clearly stated aim | Inclusion of consecutive patients | Prospective collection of data | Endpoints appropriate to the aim of the study | Unbiased assessment of the study endpoint | Follow-up period appropriate to the aim of the study | Loss to follow-up less than 5 % | Prospective calculation of the study size | An adequate control group | Contemporary groups | Baseline equivalence of groups | Adequate statistical analyses | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Anania | 2 | 2 | 1 | 2 | 1 | 2 | 0 | 0 | 2 | 1 | 2 | 2 | 17 |
| Chaves | 2 | 2 | 2 | 2 | 1 | 2 | 2 | 0 | 2 | 1 | 2 | 2 | 20 |
| Fabozzi | 2 | 1 | 0 | 2 | 1 | 2 | 2 | 0 | 2 | 2 | 2 | 1 | 17 |
| Lee | 2 | 2 | 0 | 2 | 1 | 1 | 2 | 0 | 2 | 2 | 2 | 2 | 18 |
| Magistro | 2 | 2 | 2 | 2 | 1 | 2 | 0 | 0 | 2 | 2 | 2 | 2 | 19 |
| Marchesi | 2 | 2 | 2 | 2 | 1 | 2 | 2 | 0 | 2 | 1 | 2 | 2 | 20 |
| Milone | 2 | 2 | 2 | 2 | 1 | 2 | 1 | 0 | 2 | 2 | 2 | 2 | 20 |
| Scatizzi | 2 | 2 | 2 | 2 | 1 | 2 | 2 | 0 | 2 | 2 | 2 | 2 | 21 |
| Shapiro | 2 | 2 | 2 | 2 | 1 | 1 | 2 | 0 | 2 | 2 | 2 | 2 | 20 |
| Roscio | 2 | 2 | 2 | 2 | 1 | 2 | 1 | 0 | 2 | 1 | 2 | 2 | 19 |
| Trastulli | 2 | 2 | 2 | 2 | 1 | 2 | 1 | 0 | 2 | 1 | 1 | 0 | 16 |
| Vergis | 2 | 2 | 1 | 2 | 1 | 2 | 2 | 0 | 2 | 1 | 2 | 2 | 19 |
| Not reported | 0 | 0 | 2 | 0 | 0 | 0 | 2 | 12 | 0 | 0 | 0 | 1 | 17 |
| Reported, inadequate | 0 | 1 | 2 | 0 | 12 | 2 | 3 | 0 | 0 | 6 | 1 | 1 | 28 |
| Reported, adequate | 12 | 11 | 8 | 12 | 0 | 12 | 7 | 0 | 12 | 3 | 11 | 10 | 98 |